跳至主要内容
临床试验/IRCT20231105059968N1
IRCT20231105059968N1尚未招募Unknown

Investigating the effect of Tacar treatment on improving symptoms and performance of patients with plantar fasciitis and comparing it with drug treatment

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 68 years(—)
性别
All

入选标准

  • Diagnosis of plantar fasciitis (worsening of the pain in the inner part of the heel in the morning after waking up and also after a lot of activity during the day and the presence of local tenderness in the lower inner part of the calcaneus) by a physical medicine and rehabilitation specialist with a physical examination
  • Heel pain for at least 4 weeks
  • Age between 18 and 68 years
  • Presence of VAS greater than 3
  • Informed written consent to participate in the study

排除标准

  • History of inflammatory joint disease
  • Achilles tendon or nerve damage
  • History of heel surgery or injection in the last 6 months
  • History of injury to the affected heel
  • The presence of diseases mimicking the symptoms of plantar fasciitis
  • Contraindications of the Tecar device (pregnancy, pacemaker, insulin pump, growth plate, cancer, open wound and skin lesions, skin sensitivity, insensitivity to heat)
  • Patients with intense physical activity or sports who are unable to reduce their activity level

研究者

相似试验